Compare JDZG & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JDZG | PRME |
|---|---|---|
| Founded | 2020 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 601.1M |
| IPO Year | 2024 | 2022 |
| Metric | JDZG | PRME |
|---|---|---|
| Price | $1.22 | $4.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.31 |
| AVG Volume (30 Days) | 13.3K | ★ 3.8M |
| Earning Date | 04-17-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | $2,567,741.00 | ★ $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.35 | ★ N/A |
| Revenue Growth | 20.36 | ★ 647.13 |
| 52 Week Low | $1.19 | $1.11 |
| 52 Week High | $14.00 | $6.94 |
| Indicator | JDZG | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 32.61 | 49.51 |
| Support Level | $1.21 | $3.95 |
| Resistance Level | $1.57 | $4.42 |
| Average True Range (ATR) | 0.10 | 0.31 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 2.78 | 65.09 |
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.